Related Experiment Video
Updated: Dec 9, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Promising targets and drugs in rheumatoid arthritis: a module-based and cumulatively scoring approach
Xingyan Li1, Yejing Yang1, Guili Sun2
1Department of Bone and Joint Surgery, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Aims:
Rheumatoid arthritis (RA) is a systematic autoimmune disorder, characterized by synovial inflammation, bone and cartilage destruction, and disease involvement in multiple organs. Although numerous drugs are employed in RA treatment, some respond little and suffer from severe side effects. This study aimed to screen the candidate therapeutic targets and promising drugs in a novel method.
Methods:
We developed a module-based and cumulatively scoring approach that is a deeper-layer application of weighted gene co-expression network (WGCNA) and connectivity map (CMap) based on the high-throughput datasets.
Results:
Four noteworthy RA-related modules were identified, revealing the immune- and infection-related biological processes and pathways involved in RA. HLA-DMA, HLA-DMB, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRA, HLA-DRB1, BLNK, BTK, CD3D, CD4, IL2RG, INPP5D, LCK, PTPRC, RAC2, SYK, and VAV1 were recognized as the key hub genes with high connectivity in gene regulation networks and gene pathway networks. Moreover, the long noncoding RNAs (lncRNAs) in the RA-related modules, such as FAM30A and NEAT1, were identified as the indispensable interactors with the hub genes. Finally, candidate drugs were screened by developing a cumulatively scoring approach based on the selected modules. Niclosamide and the other compounds of T-type calcium channel blocker, IKK inhibitor, and PKC activator, HIF activator, and proteasome inhibitor, which harbour the similar gene signature with niclosamide, were promising drugs with high specificity and broad coverage for the RA-related modules.
Conclusion:
This study provides not only the promising targets and drugs for RA but also a novel methodological insight into the target and drug screening.Cite this article: Bone Joint Res 2020;9(8):501-514.
Insights
This study developed a novel method to identify therapeutic targets and drugs for rheumatoid arthritis (RA). Key genes and potential drugs like niclosamide were found, offering new treatment strategies for RA.
Area of Science:
- Rheumatoid Arthritis Research
- Immunology
- Genomics
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a systemic autoimmune disease causing inflammation and joint destruction.
- Current RA treatments have limited efficacy and significant side effects for some patients.
- Novel therapeutic targets and drugs are needed for effective RA management.
Purpose of the Study:
- To screen candidate therapeutic targets for rheumatoid arthritis (RA) using a novel approach.
- To identify promising drugs for RA treatment.
- To provide methodological insights into target and drug screening for complex diseases.
Main Methods:
- Developed a module-based, cumulatively scoring approach integrating weighted gene co-expression network analysis (WGCNA) and Connectivity Map (CMap).
- Applied this method to high-throughput datasets to identify RA-related biological modules and key genes.
- Screened candidate drugs based on gene signatures within identified RA-related modules.
Main Results:
- Identified four significant RA-related modules, highlighting immune and infection pathways.
- Recognized key hub genes including HLA-DMA, HLA-DPB1, BTK, CD4, and PTPRC, crucial for RA pathogenesis.
- Identified long noncoding RNAs (lncRNAs) like FAM30A and NEAT1 as important interactors.
- Screened niclosamide and other compounds (T-type calcium channel blockers, IKK inhibitors, etc.) as promising drugs with high specificity and broad coverage for RA modules.
Conclusions:
- The study successfully identified promising therapeutic targets and candidate drugs for rheumatoid arthritis.
- The novel methodological approach offers a valuable tool for future target and drug discovery.
- Findings contribute to a better understanding of RA pathogenesis and potential treatment strategies.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Rheumatic Heart Disease III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Quantitative Aspects of Drug-Receptor Interaction

